TNFRSF11A and breast carcinoma: Conservation of C-X-C motif chemokine receptor type 4 (CXCR4 and CXCL12), receptor activator of NF-kB (RANK), and RANK ligand (RANKL) has been shown to be of great importance for targeting breast cancer cells to bone [60].